TickerFacts.

Compare

Madrigal Pharmaceuticals, Inc. vs ANI Pharmaceuticals Inc vs Prestige Consumer Healthcare Inc. vs Arrowhead Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearMadrigal Pharmaceuticals, Inc.
MDGL		ANI Pharmaceuticals Inc
ANIP		Prestige Consumer Healthcare Inc.
PBH		Arrowhead Pharmaceuticals, Inc.
ARWR
Year ended2025-12-312025-12-312026-03-312025-09-30
Revenue$958.40M$883.37M$1.09B$829.45M
Revenue growth (YoY)+432.1%+43.8%-4.3%n/m
Gross marginn/an/a54.7%n/a
Operating margin-31.3%12.6%28.4%11.9%
Net margin-30.1%8.9%17.5%3.6%
Net income-$288.28M$78.34M$190.30M$30.11M
EPS (Diluted)-$12.85$3.32$3.91-$0.01
Operating cash flow-$189.55M$185.22M$257.63M$179.55M
Free cash flow-$190.02M$171.39M$246.45M$156.89M
Cash & equivalents$198.69M$285.58M$63.87Mn/a
Total assets$1.26B$1.44B$3.49B$1.39B
Total liabilities$656.90M$899.65M$1.61Bn/a
Shareholders' equity$602.69M$540.72M$1.89B$503.42M
Return on year-end equity-47.8%14.5%10.1%6.0%
Shares outstanding22.84M22.49Mn/a135.70M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearMadrigal Pharmaceuticals, Inc.ANI Pharmaceuticals IncPrestige Consumer Healthcare Inc.Arrowhead Pharmaceuticals, Inc.
Latest$958.40M
Ended 2025-12-31		$883.37M
Ended 2025-12-31		$1.09B
Ended 2026-03-31		$829.45M
Ended 2025-09-30
1 year earlier$180.13M
Ended 2024-12-31		$614.38M
Ended 2024-12-31		$1.14B
Ended 2025-03-31		$3.55M
Ended 2024-09-30
2 years earlier$0
Ended 2023-12-31		$486.82M
Ended 2023-12-31		$1.13B
Ended 2024-03-31		$240.74M
Ended 2023-09-30
3 years earlier$0
Ended 2022-12-31		$316.38M
Ended 2022-12-31		$1.13B
Ended 2023-03-31		$243.23M
Ended 2022-09-30
4 years earlier$0
Ended 2021-12-31		$216.14M
Ended 2021-12-31		$1.09B
Ended 2022-03-31		$138.29M
Ended 2021-09-30